Abstract
Transfemoral aortic valve implantation (TAVI) is the most commonly adopted access for TAVI, as vascular injury and complication remain a concern that affects both procedural and clinical outcomes, so meticulous access site selection and preparation, perfect femoral stick, and early complication diagnosis and good management will markedly improve patient’s outcome.
In this chapter, we discuss planning and choice of the vascular access by evaluating the anatomical features of the femoral artery; we highlight the methods of femoral artery access either percutaneously or surgically. Good planning and following best practice for vascular access will reduce the vascular complications.
Predictors and incidence of vascular complication and how they affect the clinical outcome are also discussed; different types of vascular complication and their management are also illustrated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dato I, Burzotta F, Trani C, Crea F, Ussia GP. Percutaneous management of vascular access in transfemoral transcatheter aortic valve implantation. World J Cardiol. 2014;6:836–46.
Irani F, Kumar S, Colyer WR Jr. Common femoral artery access techniques: a review. J Cardiovasc Med. 2009;10:517–22.
Lechner G, Jantsch H, Waneck R, Kretschmer G. The relationship between the common femoral artery, the inguinal crease, and the inguinal ligament: a guide to accurate angiographic puncture. Cardiovasc Intervent Radiol. 1988;11:165–9.
Grier D, Hartnell G. Percutaneous femoral artery puncture: practice and anatomy. Br J Radiol. 1990;63:602–4.
Johnson LW, Krone R. Cardiac catheterization 1991: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). Catheter Cardiovasc Diagn. 1993;28:219–20.
Sandgren T, Sonesson B, Ahlgren R, Lanne T. The diameter of the common femoral artery in healthy human: influence of sex, age, and body size. J Vasc Surg. 1999;29:503–10.
Ahn HY, Lee HJ, Lee HJ, Yang JH, Yi JS, Lee IW. Assessment of the optimal site of femoral artery puncture and angiographic anatomical study of the common femoral artery. J Korean Neurosurg Soc. 2014;56:91–7.
Altin RS, Flicker S, Naidech HJ. Pseudoaneurysm and arteriovenous fistula after femoral artery catheterization: association with low femoral punctures. AJR Am J Roentgenol. 1989;152:629–31.
Cole PL, Krone RJ. Approach to reduction of vascular complications of percutaneous valvuloplasty. Catheter Cardiovasc Diagn. 1987;13:331–2.
Raphael M, Hartnell G. Femoral artery catheterization and retroperitoneal haematoma formation. Clin Radiol. 2001;56:933–4; author reply 934–5
Gabriel M, Pawlaczyk K, Waliszewski K, Krasinski Z, Majewski W. Location of femoral artery puncture site and the risk of postcatheterization pseudoaneurysm formation. Int J Cardiol. 2007;120:167–71.
Kim D, Orron DE, Skillman JJ, et al. Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. Catheter Cardiovasc Diagn. 1992;25:91–7.
Olasinska-Wisniewska A, Grygier M, Lesiak M, et al. Femoral artery anatomy-tailored approach in transcatheter aortic valve implantation. Adv Interv Cardiol. 2017;13:150–6.
Krajcer Z, Parekh D. Dynamic sheaths, in the nick of time or past their prime? Catheter Cardiovasc Interv. 2016;88:1153–4.
Abu Saleh WK, Tang GH, Ahmad H, et al. Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis. Catheter Cardiovasc Interv. 2016;88:135–43.
Koehler T, Buege M, Schleiting H, Seyfarth M, Tiroch K, Vorpahl M. Changes of the eSheath outer dimensions used for transfemoral transcatheter aortic valve replacement. Biomed Res Int. 2015;2015:572681.
Hilling-Smith R, Cockburn J, Dooley M, et al. Rapid pacing using the 0.035-in. Retrograde left ventricular support wire in 208 cases of transcatheter aortic valve implantation and balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2017;89:783–6.
Harrison GJ, How TV, Vallabhaneni SR, et al. Guidewire stiffness: what’s in a name? J Endovasc Ther. 2011;18:797–801.
Haas PC, Krajcer Z, Diethrich EB. Closure of large percutaneous access sites using the Prostar XL Percutaneous Vascular Surgery device. J Endovasc Surg. 1999;6:168–70.
Burzotta F, Paloscia L, Trani C, et al. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study. J Cardiovasc Med. 2008;9:1004–10.
Krajcer Z, Howell M. A novel technique using the percutaneous vascular surgery device to close the 22 French femoral artery entry site used for percutaneous abdominal aortic aneurysm exclusion. Catheter Cardiovasc Interv. 2000;50:356–60.
Lee WA, Brown MP, Nelson PR, Huber TS, Seeger JM. Midterm outcomes of femoral arteries after percutaneous endovascular aortic repair using the Preclose technique. J Vasc Surg. 2008;47:919–23.
Ott I, Shivaraju A, Schaffer NR, et al. Parallel suture technique with ProGlide: a novel method for management of vascular access during transcatheter aortic valve implantation (TAVI). EuroIntervention. 2017;13:928–34.
Maniotis C, Andreou C, Karalis I, Koutouzi G, Agelaki M, Koutouzis M. A systematic review on the safety of Prostar XL versus ProGlide after TAVR and EVAR. Cardiovasc Revasc Med. 2017;18:145–50.
Spitzer SG, Wilbring M, Alexiou K, Stumpf J, Kappert U, Matschke K. Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI? Catheter Cardiovasc Interv. 2016;88:E52–8.
Garcia E, Martin-Hernandez P, Unzue L, Hernandez-Antolin RA, Almeria C, Cuadrado A. Usefulness of placing a wire from the contralateral femoral artery to improve the percutaneous treatment of vascular complications in TAVI. Revista Esp Cardiol. 2014;67:410–2.
Van Mieghem NM, Tchetche D, Chieffo A, et al. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol. 2012;110:1361–7.
Shoeib O, Burzotta F. Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage: angiographic evidence and predictors for a new side effect. Catheter Cardiovasc Interv. 2018;91:938–44.
Malyar NM, Kaier K, Freisinger E, et al. Prevalence and impact of critical limb ischaemia on in-hospital outcome in transcatheter aortic valve implantation in Germany. EuroIntervention. 2017;13:1281–7.
Blakeslee-Carter J, Dexter D, Mahoney P, et al. A novel iliac morphology score predicts procedural mortality and major vascular complications in transfemoral aortic valve replacement. Ann Vasc Surg. 2018;46:208–17.
Torsello GB, Kasprzak B, Klenk E, Tessarek J, Osada N, Torsello GF. Endovascular suture versus cutdown for endovascular aneurysm repair: a prospective randomized pilot study. J Vasc Surg. 2003;38:78–82.
Stortecky S, Wenaweser P, Diehm N, et al. Percutaneous management of vascular complications in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012;5:515–24.
Vidi VD, Matheny ME, Govindarajulu US, et al. Vascular closure device failure in contemporary practice. JACC Cardiovasc Interv. 2012;5:837–44.
Hayashida K, Lefevre T, Chevalier B, et al. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications. JACC Cardiovasc Interv. 2012;5:207–14.
Stone PA, Campbell JE, AbuRahma AF. Femoral pseudoaneurysms after percutaneous access. J Vasc Surg. 2014;60:1359–66.
Stone PA, Martinez M, Thompson SN, et al. Ten-year experience of vascular surgeon management of iatrogenic pseudoaneurysms: do anticoagulant and/or antiplatelet medications matter? Ann Vasc Surg. 2016;30:45–51.
Mlekusch W, Haumer M, Mlekusch I, et al. Prediction of iatrogenic pseudoaneurysm after percutaneous endovascular procedures. Radiology. 2006;240:597–602.
Kent KC, McArdle CR, Kennedy B, Baim DS, Anninos E, Skillman JJ. Accuracy of clinical examination in the evaluation of femoral false aneurysm and arteriovenous fistula. Cardiovasc Surg. 1993;1:504–7.
Hanson JM, Atri M, Power N. Ultrasound-guided thrombin injection of iatrogenic groin pseudoaneurysm: Doppler features and technical tips. Br J Radiol. 2008;81:154–63.
Paulson EK, Hertzberg BS, Paine SS, Carroll BA. Femoral artery pseudoaneurysms: value of color Doppler sonography in predicting which ones will thrombose without treatment. AJR Am J Roentgenol. 1992;159:1077–81.
Samuels D, Orron DE, Kessler A, et al. Femoral artery pseudoaneurysm: Doppler sonographic features predictive for spontaneous thrombosis. J Clin Ultrasound. 1997;25:497–500.
Fellmeth BD, Roberts AC, Bookstein JJ, et al. Postangiographic femoral artery injuries: nonsurgical repair with US-guided compression. Radiology. 1991;178:671–5.
Khoury M, Rebecca A, Greene K, et al. Duplex scanning-guided thrombin injection for the treatment of iatrogenic pseudoaneurysms. J Vasc Surg. 2002;35:517–21.
Stone P, Lohan JA, Copeland SE, Hamrick RE Jr, Tiley EH 3rd, Flaherty SK. Iatrogenic pseudoaneurysms: comparison of treatment modalities, including duplex-guided thrombin injection. W V Med J. 2003;99:230–2.
Lonn L, Olmarker A, Geterud K, Risberg B. Prospective randomized study comparing ultrasound-guided thrombin injection to compression in the treatment of femoral pseudoaneurysms. J Endovasc Ther. 2004;11:570–6.
Dzijan-Horn M, Langwieser N, Groha P, et al. Safety and efficacy of a potential treatment algorithm by using manual compression repair and ultrasound-guided thrombin injection for the management of iatrogenic femoral artery pseudoaneurysm in a large patient cohort. Circ Cardiovasc Interv. 2014;7:207–15.
Masson JB, Al Bugami S, Webb JG. Endovascular balloon occlusion for catheter-induced large artery perforation in the catheterization laboratory. Catheter Cardiovasc Interv. 2009;73:514–8.
Lagana D, Carrafiello G, Mangini M, et al. Emergency percutaneous treatment of arterial iliac axis ruptures. Emerg Radiol. 2007;14:173–9.
Goltz JP, Basturk P, Hoppe H, Triller J, Kickuth R. Emergency and elective implantation of covered stent systems in iatrogenic arterial injuries. RoFo. 2011;183:618–30.
Masson JB, Kovac J, Schuler G, et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv. 2009;2:811–20.
Hayashida K, Lefevre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4:851–8.
Van Mieghem NM, Nuis RJ, Piazza N, et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention. 2010;5:673–9.
Ducrocq G, Francis F, Serfaty JM, et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention. 2010;5:666–72.
Généreux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012;60:1043–52.
Czerwinska-Jelonkiewicz K, Michalowska I, Witkowski A, et al. Vascular complications after transcatheter aortic valve implantation (TAVI): risk and long-term results. J Thromb Thrombolysis. 2014;37:490–8.
Mwipatayi BP, Picardo A, Masilonyane-Jones TV, et al. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation. J Vasc Surg. 2013;58:1028–36.e1.
Steinvil A, Leshem-Rubinow E, Halkin A, et al. Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions. Am J Cardiol. 2015;115:100–6.
Perrin N, Ellenberger C, Licker M, et al. Management of vascular complications following transcatheter aortic valve implantation. Arch Cardiovasc Dis. 2015;108:491–501.
Uguz E, Gokcimen M, Ali S, et al. Predictability and outcome of vascular complications after transfemoral transcatheter aortic valve implantation. J Heart Valve Dis. 2016;25:173–81.
Okuyama K, Jilaihawi H, Abramowitz Y, et al. The clinical impact of vascular complications as defined by VARC-1 vs. VARC-2 in patients following transcatheter aortic valve implantation. EuroIntervention. 2016;12:e636–42.
Sinning JM, Horack M, Grube E, et al. The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry. Am Heart J. 2012;164:102–10.e1.
Kim BG, Ko YG, Hong S-J, Ahn C-M, Kim JS, Kim B-K, Choi D, Jang Y, Hong MK, Lee SH, Lee S, Chang B-C. Impact of peripheral artery disease on early and late outcomes in patients who underwent transcatheter aortic valve implantation CCT. Int J Cardiol. 2018;255:206–11.
Fanaroff AC, Manandhar P, Holmes DR, et al. Peripheral artery disease and transcatheter aortic valve replacement outcomes: a report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Therapy Registry. Circ Cardiovasc Interv. 2017;10:e005456.
Disclosures
Dr. Burzotta discloses to have been involved in advisory board meetings or having received speaker’s fees from Medtronic, St Jude Medical, Abiomed, Biotronic. Dr. Trani discloses to have been involved in advisory board meetings or having received speaker’s fees from St Jude Medical, Abiomed, Biotronic.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Burzotta, F., Shoeib, O., Trani, C. (2019). Access Management for Transfemoral Transcatheter Aortic Valve Implantation. In: Giordano, A., Biondi-Zoccai, G., Frati, G. (eds) Transcatheter Aortic Valve Implantation. Springer, Cham. https://doi.org/10.1007/978-3-030-05912-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-05912-5_18
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-05911-8
Online ISBN: 978-3-030-05912-5
eBook Packages: MedicineMedicine (R0)